Influx Healthtech (NSE:INFLUX) Beneish M-Score: -0.78 (As of Jul. 03, 2026)


NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
21 GF Score
Price ₹292.60
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech Beneish M-Score?

Influx Healthtech NSE:INFLUX +2.49% 21 Beneish M-Score is -0.78 as of Jul. 03, 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 909 Drug Manufacturers companies, Influx Healthtech ranks worse than 93.07% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.78 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Influx Healthtech's Beneish M-Score or its related term are showing as below:

NSE:INFLUX' s Beneish M-Score Range Over the Past 10 Years
Min: -2.21   Med: -1.3   Max: -0.78
Current: -0.78

During the past 5 years, the highest Beneish M-Score of Influx Healthtech was -0.78. The lowest was -2.21. And the median was -1.30.

Influx Healthtech Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech Beneish M-Score Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
0.00 0.00 -2.21 -1.30 -0.78

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial -2.21 0.00 -1.30 0.00 -0.78

NSE:INFLUX vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Influx Healthtech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Influx Healthtech Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Influx Healthtech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Influx Healthtech's Beneish M-Score falls into.


NSE:INFLUX
21GF Score
Influx Healthtech Ltd NSE:INFLUX
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Influx Healthtech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8177+0.528 * 0.7563+0.404 * 2.496+0.892 * 1.4111+0.115 * 1.2073
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.134614-0.327 * 0.3805
=-0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹377 Mil.
Revenue was ₹1,468 Mil.
Gross Profit was ₹601 Mil.
Total Current Assets was ₹815 Mil.
Total Assets was ₹1,237 Mil.
Property, Plant and Equipment(Net PPE) was ₹310 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹38 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹227 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.
Net Income was ₹205 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹39 Mil.
 Total Receivables was ₹327 Mil.
Revenue was ₹1,041 Mil.
Gross Profit was ₹322 Mil.
Total Current Assets was ₹490 Mil.
Total Assets was ₹703 Mil.
Property, Plant and Equipment(Net PPE) was ₹187 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹28 Mil.
Selling, General, & Admin. Expense(SGA) was ₹26 Mil.
Total Current Liabilities was ₹339 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(377.153 / 1468.336) / (326.869 / 1040.584)
=0.256857 / 0.314121
=0.8177

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(322.355 / 1040.584) / (601.425 / 1468.336)
=0.309783 / 0.409596
=0.7563

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (814.628 + 310.213) / 1237.03) / (1 - (490.198 + 187.25) / 702.991)
=0.090692 / 0.036335
=2.496

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1468.336 / 1040.584
=1.4111

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(28.244 / (28.244 + 187.25)) / (37.78 / (37.78 + 310.213))
=0.131066 / 0.108565
=1.2073

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 1468.336) / (26.201 / 1040.584)
=0 / 0.025179
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 227.116) / 1237.03) / ((0 + 339.238) / 702.991)
=0.183598 / 0.482564
=0.3805

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(205.387 - 0 - 38.865) / 1237.03
=0.134614

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Influx Healthtech has a M-score of -0.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.78 mean?
Influx Healthtech (NSE:INFLUX) has a Beneish M-Score of -0.78 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Influx Healthtech and its competitors. According to the industry distribution chart, Influx Healthtech ranks #846 out of 909 companies in the Drug Manufacturers industry, placing it in the top 93.1%.
Is Influx Healthtech's Beneish M-Score too high?
Influx Healthtech's current Beneish M-Score is -0.78. Based on the distribution chart, Influx Healthtech ranks #846 out of 909 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Influx Healthtech ranks #846 out of 909 companies for Beneish M-Score. This places Influx Healthtech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Influx Healthtech and its competitors. Influx Healthtech's current Beneish M-Score is -0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Beneish M-Score of -0.78. The current Beneish M-Score is -0.78. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Beneish M-Score is -0.78 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score

Get the complete analysis for NSE:INFLUX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹292.60
Price